Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cost of Wegovy 7.2mg in the UK private market varies by provider, and any legitimate price will include a prescription issued following clinical assessment — it cannot legally be sold any other way. Since Novo Nordisk's higher-dose approvals, private monthly prices for semaglutide treatment have ranged roughly between £149 and £375 depending on the dose and provider, based on widely reported market figures. Wegovy 7.2mg sits at the top of that range. As a prescription-only medicine, it requires a prescriber to judge your suitability; the cost of that clinical assessment is part of what a responsible provider charges. What varies significantly between providers is what else that price covers — and that gap matters more than it first appears. Learn more about how Wegovy works if you want the clinical picture first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The MHRA approved a dedicated single-dose 7.2mg Wegovy pen on 14 April 2026, confirmed by a GOV.UK announcement that same day. It is the highest dose available in the semaglutide range, licensed for adults with a BMI of 30 or above, reached by titrating up from a 0.25mg starting dose over several months under prescriber guidance. Trial data at 7.2mg reported average weight reductions of around 20.7% over 72 weeks, meaningfully closer to the results seen with tirzepatide at its highest doses. That approval made Wegovy a more capable treatment for more patients, but it also pushed the cost of a monthly supply higher than earlier dose options, and if you want to understand exactly what that means in practice, our page on what Wegovy 7.2mg costs in the UK sets out the current figures in detail. Providers set their own prices, so what you see advertised varies. The important question is not which number is smallest, but what the number includes.
For a deeper look at how prices break down across the dose ladder, our Wegovy cost and pricing guide covers the broader picture.
A figure advertised for Wegovy 7.2mg may reflect the medicine alone. Some providers add separate charges for the consultation, the prescription itself, delivery, or ongoing clinical reviews when you request a repeat. These extras can arrive at checkout rather than at the point of comparison, which means two prices that look similar can represent very different overall costs once everything is totted up, and our dedicated page on the full cost of Wegovy 7.2mg walks through what those additional charges typically look like.
There are also softer costs that rarely appear on a pricing page: what happens if you have a question about a side effect on a Saturday evening, or need a dose review mid-cycle? Some providers include clinical support as standard; others do not. The Wegovy price guide on our site sets this out in more detail, but the short version is that a headline price is rarely the full picture.
This is not a criticism of any particular provider. It is the honest reality of how UK private weight-loss treatment is structured, and it is worth knowing before you decide.
We are not the cheapest option. That is a deliberate choice, not an oversight. One transparent price covers the consultation, the prescription, the medicine, next-working-day tracked DPD delivery, and seven-day aftercare, no repeat charges, no subscriptions, no auto-renewals. Every repeat order is looked at again by a prescriber before anything is dispensed. Our pharmacy holds GPhC premises registration 9012878, which anyone can verify on the GPhC register.
If you order by midday on a working day and your consultation is clinically approved, your treatment is dispatched the same day. That 12pm cut-off is firm (miss it by a few minutes and the next dispatch slot is the following morning) but it means most patients have their pen the next working day rather than waiting several. Specific dose and pen-format availability is confirmed at consultation, because clinical suitability shapes what is prescribed. You can see current treatment options at our treatment page.
Our clinical team's approach is set out on our prescriber profile page if you want to understand who reviews your consultation.
The MHRA has warned repeatedly about fake weight-loss pens circulating online, including counterfeit semaglutide products seized in large enforcement operations through 2024 and 2025. Counterfeit pens have contained incorrect substances; hospitalisations have been reported. The safest prompt to take seriously is a price that sits far below the going market rate, or a seller that does not require a clinical assessment before supplying, and our guide to what Wegovy 1mg costs is a useful reference point for understanding where the dose ladder begins and how pricing scales from there. According to NHS guidance on semaglutide, this is a prescription-only medicine that requires clinical oversight, shortcuts on that front are where real risk lives.
For a prescription medicine at the highest licensed dose, the right question is not which provider charges least. It is whether the provider is regulated, whether a real prescriber is making the clinical decision, and whether support is available if something goes wrong. A small difference in price does not compensate for a gap in any of those areas. If you have questions before starting, our FAQ page covers the most common ones, and the weight-loss treatment overview explains your options in plain terms.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.